Recent Finacing
Recent Raise
Amplyx Pharmaceuticals develops antifungal therapies and antiviral monoclonal antibodies for immunocompromised patients, advancing fosmanogepix (APX001) and MAU868 through clinical development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Amplyx Pharmaceuticals.
